Biolargo, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 17, 2020 at 03:52 am IST
Share
BioLargo, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was USD 666,000 compared to USD 534,000 a year ago. Operating loss was USD 1.909 million compared to USD 1.884 million a year ago. Net loss was USD 2.106 million compared to USD 3.679 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago. For the nine months, total revenue was USD 1.522 million compared to USD 1.324 million a year ago. Operating loss was USD 5.615 million compared to USD 5.034 million a year ago. Net loss was USD 6.806 million compared to USD 8.053 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.06 a year ago.
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company invents, develops, and commercializes platform technologies to solve challenging environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor control, air quality control, infection control, and myriad environmental remediation challenges. The Companyâs segments include ONM Environmental, which manufactures and sells its odor and VOC control products and services, including its flagship product, CupriDyne Clean; BLEST, which provides professional engineering services supporting its internal business units; Clyra Medical, which develops and sells medical products based on its technology; BioLargo Canada, which is primary engaged in research and development activities; and Corporate Operations, which support the operating segments with legal, accounting, human resources, and other services.
BIOLARGO, INC. 
